glp 1 agonist dementia GLP-1R agonists protect against Alzheimer's disease by rewiring energy regulation Neuroprotective effects of GLP-1 receptor
Description
doi: 10.1016/j.mce.2015.07.003 40 ClemmensenCFinanBMllerTDDiMarchiRDTschpMHHofmannSM

Aigner, T., Haag, J., Martin, J

Diabetes (2004) 53(3):65462

Because Wegovy are prescription medicines, suitability is assessed by a doctor who reviews medical history, medications, and blood tests

The 5- and 10-year survival probabilities in this matched obesity cohort favored GLP-1 receptor agonist users, and the authors interpreted these data as suggesting a potentially meaningful long-term association between GLP-1 receptor agonist exposure and improved outcomes in this group

doi:10.3390/jcm14113812 10.Jastreboff AM, Ryan DH, Bays HE, et al
